AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Sponsored by Cordio Medical
About this study
Study Design: This is an international, multicenter, observational, non-interventional, prospective, blinded, single-arm, two-period study, to collect patient utterances that will be retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.
Two periods: Run-In period will be a period in which patients will submit daily recordings, baseline creation Core period will be a period in which patients will be followed up and will continually submit daily recordings for up-to 24 months per patient or until End-of-Study (EOS), whichever comes first.
Where this study is enrolling (37)
- I'm interested
Eastern Shore Research Institute
Fairhope, Alabama
- I'm interested
VA San Diego
San Diego, California
- I'm interested
VA Loma Linda Healthcare System
Loma Linda, California
- I'm interested
Kaiser Permanente San Francisco
San Francisco, California
- I'm interested
University of California, San Francisco
San Francisco, California
Show all 37 locations
- I'm interested
UC San Diego Health
La Jolla, California
- I'm interested
Tampa General Hospital
Tampa, Florida
- I'm interested
Nature Coast Clinical Research
Crystal River, Florida
- I'm interested
St. Johns Center for Clinical Research
Saint Augustine, Florida
- I'm interested
Advance Medical Research Services Corp (AMRS)
Miami, Florida
- I'm interested
Amavita Clinical Research
Miami, Florida
- I'm interested
Baptist Health (Miami Cardiac & Vascular Institute)
Miami, Florida
- I'm interested
Comprehensive Medical & Research Center
Plantation, Florida
- I'm interested
Jacksonville Center for Clinical Research
Jacksonville, Florida
- I'm interested
West Georgia Cardiology
Carrollton, Georgia
- I'm interested
University of Chicago
Chicago, Illinois
- I'm interested
Advocate Illinois Masonic Medical Center
Chicago, Illinois
- I'm interested
Midwest Cardiovascular Center
Naperville, Illinois
- I'm interested
Advocate Illinois Masonic Health Center
Downers Grove, Illinois
- I'm interested
Robert J. Dole VA Medical Center
Wichita, Kansas
- I'm interested
St. Elizabeth Healthcare
Edgewood, Kentucky
- I'm interested
University Medical Center New Orleans
New Orleans, Louisiana
- I'm interested
Cardiovascular Institute of the South
Lafayette, Louisiana
- I'm interested
Cardiovascular Institute of the South
Houma, Louisiana
- I'm interested
Nebraska Heart Center
Lincoln, Nebraska
- I'm interested
VA Southern Nevada Healthcare System
North Las Vegas, Nevada
- I'm interested
The Mount Sinai Hospital
New York, New York
- I'm interested
Mount Sinai Morningside
New York, New York
- I'm interested
St. Francis Hospital
Roslyn, New York
- I'm interested
Moses H. Cone Memorial Hospital
Greensboro, North Carolina
- I'm interested
Mission Hospital
Asheville, North Carolina
- I'm interested
The Lindner Research Center at The Christ Hospital
Cincinnati, Ohio
- I'm interested
Cleveland Clinic
Cleveland, Ohio
- I'm interested
The Ohio State University
Columbus, Ohio
- I'm interested
Vanderbilt University Medical Center
Nashville, Tennessee
- I'm interested
Rio Grande Regional Hospital
McAllen, Texas
- I'm interested
Methodist Hospital of San Antonio
San Antonio, Texas
Who can participate
Inclusion criteria
- ✓1. Age 22 or greater
- ✓2. Diagnosed with Symptomatic Chronic Heart Failure \[NYHA II-IVa (ambulatory)\]
- ✓3. At least one of the following:
- ✓1. One ADHF hospitalization in the last 12 months
- ✓2. One unplanned IV/SC diuretic administration in the last 6 months
- ✓3. Two unplanned IV/SC diuretic administrations in the last 12 months
- ✓4. NTProBNP \>500 pg/ml
- ✓4. Clinically stable HF according to investigator discretion
- ✓5. Willing to participate as evidenced by signing the written informed consent.
- ✓Major
Exclusion criteria
- ✕1. Unable to comply with daily use of the App,
- ✕2. Has had a major cardiovascular event within 3 months prior to enrolment.
- ✕3. Had a Cardiac Resynchronization Therapy Device (CRT) implanted or upgrading ≤ 1 month prior to screening visit.
- ✕4. Has estimated Glomerular Filtration Rate (eGFR) \< 30 ml/min/1.73.
- ✕5. Is likely to undergo heart transplantation/ LVAD within 6 months of Screening Visit.
- ✕6. Was treated for a significant COPD
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.